Detalhe da pesquisa
1.
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.
Oncologist
; 27(5): 344-351, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348756
2.
Fulvestrant in management of hormone receptor-positive metastatic breast cancer.
Future Oncol
; 14(18): 1789-1800, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29783894
3.
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach.
iScience
; 26(1): 105799, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36619972
4.
Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.
Clin Breast Cancer
; 22(4): e536-e543, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184934
5.
Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases.
Curr Probl Cancer Case Rep
; 22020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34505091
6.
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.
Cancer Cell
; 37(3): 387-402.e7, 2020 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142667
7.
Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer.
Chin Clin Oncol
; 7(3): 25, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30056727
8.
Surgery for CNS Tumors in the Brazilian National Health Care System.
J Glob Oncol
; 3(2): 157-161, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717753
9.
Breast Cancer Patient-Derived Xenografts: Pros, Cons, and Next Steps.
J Natl Cancer Inst
; 109(7)2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28376181
10.
Skin Necrosis After Ado-Trastuzumab Emtansine Extravasation.
J Oncol Pract
; 13(8): 555-556, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678590